000 01366 a2200385 4500
005 20250514182247.0
264 0 _c20040525
008 200405s 0 0 eng d
022 _a0007-1048
024 7 _a10.1111/j.1365-2141.2004.04871.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPerifanis, Vasilios
245 0 0 _aTreatment of beta-thalassaemia-associated osteoporosis with zoledronic acid.
_h[electronic resource]
260 _bBritish journal of haematology
_cApr 2004
300 _a91-2; author reply 93-4 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAdult
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImidazoles
_xtherapeutic use
650 0 4 _aInsulin-Like Growth Factor I
_xmetabolism
650 0 4 _aMale
650 0 4 _aOsteoporosis
_xdrug therapy
650 0 4 _aZoledronic Acid
650 0 4 _abeta-Thalassemia
_xcomplications
700 1 _aVyzantiadis, Timos
700 1 _aVakalopoulou, Sofia
700 1 _aTziomalos, Konstantinos
700 1 _aGarypidou, Vasilia
700 1 _aAthanassiou-Metaxa, Miranta
700 1 _aHarsoulis, Fedon
773 0 _tBritish journal of haematology
_gvol. 125
_gno. 1
_gp. 91-2; author reply 93-4
856 4 0 _uhttps://doi.org/10.1111/j.1365-2141.2004.04871.x
_zAvailable from publisher's website
999 _c14735575
_d14735575